Zoya Alteber
Vice President Preclinical Development Edity Therapeutics
Dynamic and impact-driven leader with 15+ years of experience driving innovation, leading high-performing teams, and managing complex research and cross-functional programs.
Proven ability to build and scale teams, foster collaboration, and oversee programs from early discovery to clinical development. Skilled in navigating organizational challenges, optimizing operations, and aligning research with business strategy to accelerate growth.
A strong advocate for leadership excellence, talent development, and executional success in fast-paced, evolving environments.
Seminars
Thursday 26th February 2026
Translating Precision Protein Delivery into the Clinic: Designing Trials for ED007’s Novel Immune-Activating Platform
10:15 am
- Present translational data supporting ED007’s CAR-guided delivery of proinflammatory immune sensor proteins into cancer cells
- Discuss how AI-engineered proteins convert tumours into inflammation hubs to engage both innate and adaptive immunity
- Outline clinical trial design strategies to evaluate safety, efficacy, and immune activation in solid tumours resistant to checkpoint inhibitors
